Brief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4

Obsidian Therapeutics

04/09/2024 12:30

Sept 4 (Reuters) - 
  
    * GALERA THERAPEUTICS-ON AUG 31, WAS NOTIFIED THAT NASDAQ
WILL
DELIST CO'S COMMON STOCK BY FILING FORM 25 WITH SEC ON SEPT 4
    * GALERA THERAPEUTICS - DELISTING IS EXPECTED TO BECOME
EFFECTIVE
TEN DAYS AFTER FILING OF FORM 25

Source text for Eikon:  ID:n0001193125-24-212627 

 ((Reuters.Briefs@thomsonreuters.com;))